Q2 2019 Pacira Biosciences Inc Earnings Call Transcript
Good day, ladies and gentlemen, and welcome to the Second Quarter 2019 Pacira BioSciences, Inc. Earnings Conference Call. (Operator Instructions) As a reminder, this conference is being recorded.
I would like to introduce your host for today's conference, Ms. Susan Mesco, Head of Investor Relations. Ma'am, please go ahead.
Thank you, Michelle, and good morning, everyone. Welcome to today's conference call to discuss our second quarter 2019 financial results. Joining me on today's call are Dave Stack, Chairman and Chief Executive Officer; Max Reinhardt, who recently joined us as President; and Charlie Reinhart, Chief Financial Officer.
Dr. Rich Scranton, Chief Medical Officer, is also here and will be available for questions following our formal remarks.
Before we start, let me remind you that today's call will include forward-looking statements based on current expectations. Such statements represent our judgment as of today and may involve risks and uncertainties. Please refer to our filings with the SEC, which are available
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |